TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
+8.37%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.84B
AUM Growth
-$2.1B
(-35%)
Cap. Flow
-$2.53B
Cap. Flow
% of AUM
-65.73%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
6,382
New
829
Increased
1,885
Reduced
2,768
Closed
710
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$179M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$26.5M |
| 3 |
iShares Semiconductor ETF
SOXX
|
$12.8M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$11.3M |
| 5 |
iShares Russell 3000 ETF
IWV
|
$9.83M |
Top Sells
| 1 |
Apple
AAPL
|
$127M |
| 2 |
Microsoft
MSFT
|
$122M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$73.2M |
| 4 |
Amazon
AMZN
|
$72.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$53.5M |
Sector Composition
| 1 | Technology | 19.08% |
| 2 | Consumer Discretionary | 11.67% |
| 3 | Healthcare | 9.59% |
| 4 | Financials | 9.24% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
O'Reilly Automotive
ORLY
$88.1B
| $2.64M | 0.07% |
69,975
-62,340
| -47% | -$2.35M |
|
227
Cleveland-Cliffs
CLF
$5.55B
| $2.64M | 0.07% |
122,242
+49,677
| +68% | +$1.07M |
|
228
Masimo
MASI
$7.9B
| $2.64M | 0.07% |
10,867
+3,872
| +55% | +$939K |
|
229
NovoCure
NVCR
$1.35B
| $2.63M | 0.07% |
11,854
+5,494
| +86% | +$1.22M |
|
230
ARK Genomic Revolution ETF
ARKG
$1.06B
| $2.61M | 0.07% |
+28,220
| New | +$2.61M |
|
231
iShares MSCI USA Size Factor ETF
SIZE
$366M
| $2.61M | 0.07% |
20,138
+19,602
| +3,657% | +$2.54M |
|
232
Regency Centers
REG
$13.3B
| $2.6M | 0.07% |
40,627
+8,697
| +27% | +$557K |
|
233
Morgan Stanley
MS
$236B
| $2.6M | 0.07% |
28,348
-175,978
| -86% | -$16.1M |
|
234
Performance Food Group
PFGC
$16.3B
| $2.59M | 0.07% |
53,485
+41,090
| +332% | +$1.99M |
|
235
SoFi Technologies
SOFI
$29.5B
| $2.57M | 0.07% |
133,931
+133,830
| +132,505% | +$2.57M |
|
|
NUAN
236
DELISTED
Nuance Communications, Inc.
NUAN
| $2.57M | 0.07% |
47,114
+32,718
| +227% | +$1.78M |
|
237
ProShares UltraPro Short S&P 500
SPXU
$527M
| $2.55M | 0.07% |
27,961
+994
| +4% | +$90.5K |
|
238
Viatris
VTRS
$12.2B
| $2.55M | 0.07% |
178,164
+83,490
| +88% | +$1.19M |
|
239
ALPS Medical Breakthroughs ETF
SBIO
$86.2M
| $2.54M | 0.07% |
51,955
+39,956
| +333% | +$1.95M |
|
240
Boston Scientific
BSX
$159B
| $2.54M | 0.07% |
59,357
-81,716
| -58% | -$3.49M |
|
241
Darling Ingredients
DAR
$5.09B
| $2.53M | 0.07% |
37,453
+17,305
| +86% | +$1.17M |
|
242
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$677M
| $2.53M | 0.07% |
1,807
+719
| +66% | +$1.01M |
|
243
Entergy
ETR
$39B
| $2.51M | 0.07% |
50,382
-2,744
| -5% | -$137K |
|
244
SPDR S&P 1500 Momentum Tilt ETF
MMTM
$146M
| $2.51M | 0.07% |
13,828
+13,795
| +41,803% | +$2.51M |
|
245
CoStar Group
CSGP
$37.8B
| $2.5M | 0.07% |
30,184
-6,006
| -17% | -$497K |
|
246
Regeneron Pharmaceuticals
REGN
$60.5B
| $2.5M | 0.07% |
4,473
-11,412
| -72% | -$6.38M |
|
247
NetEase
NTES
$84.7B
| $2.48M | 0.06% |
21,516
+424
| +2% | +$48.9K |
|
248
Expedia Group
EXPE
$26.2B
| $2.47M | 0.06% |
15,099
+2,795
| +23% | +$457K |
|
249
CACI
CACI
$10.4B
| $2.45M | 0.06% |
9,611
-7,914
| -45% | -$2.02M |
|
250
iShares Russell 1000 ETF
IWB
$43.3B
| $2.45M | 0.06% |
10,123
-3,641
| -26% | -$882K |
|